JAK2 and myeloproliferative disorder: Activation of the JAK2/STAT1 pathway, not necessarily through phosphorylated STAT1, is related to myeloproliferative neoplasms (Chen et al, 2010), and blockade of IFNγ reduced melanomagenesis (Zaidi et al, 2011).